Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jun 29, 2021

Dr. Jennifer Gudeman was hired for the newly formed role of Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals. We talk about the clinical development of their lead investigational product FT218 to treat the rare disease narcolepsy. Optimized the drug delivery release of sodium oxybate with their proprietary controlled-release technology allows for a single bedtime dose.

While the FDA nearly 20 years ago approved sodium oxybate to treat cataplexy and excessive daytime sleepiness, the drug was an immediate-release medication requiring a middle-of-the-night dose. After a successful Phase 3 clinical trial, Avadel's ongoing open-label study, RESTORE, is providing evidence that points to more restorative sleep across a broad audience.

@AvadelPharma $AVDL #narcolepsy #cataplexy #sleepdisorders #sleep #EDS #neurotwitter #rarediseases

Avadel.com

Download the transcript here

Avadel Pharmaceuticals